Ubs Oconnor LLC Connect Biopharma Holdings LTD Transaction History
Ubs Oconnor LLC
- $1.51 Billion
- Q4 2024
A detailed history of Ubs Oconnor LLC transactions in Connect Biopharma Holdings LTD stock. As of the latest transaction made, Ubs Oconnor LLC holds 510,701 shares of CNTB stock, worth $490,272. This represents 0.04% of its overall portfolio holdings.
Number of Shares
510,701Holding current value
$490,272% of portfolio
0.04%Shares
7 transactions
Others Institutions Holding CNTB
# of Institutions
17Shares Held
3.28MCall Options Held
14KPut Options Held
0-
Bml Capital Management, LLC Zionsville, IN2.09MShares$2.01 Million1.79% of portfolio
-
Choreo, LLC Minneapolis, MN161KShares$154,4320.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny135KShares$129,3090.0% of portfolio
-
Black Rock Inc. New York, NY104KShares$99,7350.0% of portfolio
-
Royal Bank Of Canada Toronto, A680.4KShares$77,1840.0% of portfolio
About Connect Biopharma Holdings Ltd
- Ticker CNTB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,015,800
- Market Cap $52.8M
- Description
- Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...